Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small ...

A UK-led international clinical trial is recruiting 280 patients to see if the technique to remove cancerous cells could ...

Erectile dysfunction in men may signal early kidney disease. A doctor explains the connection, warning signs, risk factors, and why timely medical evaluation matters.

Detailed price information for Can-Fite Biopharma Ltd ADR (CANF-A) from The Globe and Mail including charting and trades.

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $3.0 and $105.0 for Hims & Hers Health, spanning the last three ...

Male fertility issues have been identified as contributing to nearly half of the reasons couples face difficulties conceiving ...

In locally recurrent rectal cancer, neoadjuvant chemo-reirradiation plus surgery with IOERT showed no grade 4–5 toxicities ...

That wide-ranging impact is why Popular Science chose the drops as the 2025 Health category winner. This year’s list also ...

The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with ...

Coming off antidepressants is notoriously difficult, with many experiencing horrendous side-effects including stomach ...

Roughly half of Americans have prediabetes or diabetes, including an increasing number of children. High blood levels of ...